1.Type of personnel changed (please enter: spokesperson, acting spokesperson, important personnel (CEO, COO, CMO, CSO, etc.), financial officer, accounting officer, corporate governance officer, chief information security officer,research and development officer, internal audit officer, or designated and non-designated representatives):CFO

2.Date of occurrence of the change:2024/03/11

3.Name, title, and resume of the previous position holder:NA.

4.Name, title, and resume of the new position holder:Jung-Liang Kao, Senior Division Director of the Company;Chief Audit Executive of TTY Biopharm Company Limited;Auditor General,CFO, and acting spokesperson of 104 CORPORATION;Senior Director of Audit Department of PwC Taiwan.

5.Type of change (please enter: ”resignation”, ”position adjustment”, ”dismissal”, ”retirement”, ”death” or ”new replacement”):New replacement

6.Reason for the change:New replacement

7.Effective date:2024/04/01

8.Any other matters that need to be specified:The newly appointed CFO will take office on April 1, 2024.